Study Stopped
Poor accrual
Bevacizumab and Retinal Vascular Occlusions
1 other identifier
interventional
N/A
1 country
1
Brief Summary
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 30, 2006
CompletedFirst Posted
Study publicly available on registry
July 4, 2006
CompletedJune 3, 2024
May 1, 2024
Same day
June 30, 2006
May 31, 2024
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography
You may not qualify if:
- Previous surgery
- Uveitis
- Glaucoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asociacion para Evitar la Ceguera en Mexico
México, D.F. Mexico, 04030, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Griselda Alvarez, Fellow
Asociación para Evitar la Ceguera en México
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 30, 2006
First Posted
July 4, 2006
Study Start
June 1, 2006
Primary Completion
June 1, 2006
Study Completion
June 1, 2006
Last Updated
June 3, 2024
Record last verified: 2024-05